GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Net Income (Continuing Operations)

Newbury Pharmaceuticals AB (OSTO:NEWBRY) Net Income (Continuing Operations) : kr-15.41 Mil (TTM As of Aug. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Newbury Pharmaceuticals AB Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Newbury Pharmaceuticals AB's Net Income (Continuing Operations) for the three months ended in Aug. 2024 was kr1.74 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Aug. 2024 was kr-15.41 Mil.

Newbury Pharmaceuticals AB Net Income (Continuing Operations) Historical Data

The historical data trend for Newbury Pharmaceuticals AB's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newbury Pharmaceuticals AB Net Income (Continuing Operations) Chart

Newbury Pharmaceuticals AB Annual Data
Trend Aug21 Aug22 Aug23 Aug24
Net Income (Continuing Operations)
-5.56 -14.67 -19.43 -15.41

Newbury Pharmaceuticals AB Quarterly Data
Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.75 -3.52 -4.96 -8.66 1.74

Newbury Pharmaceuticals AB Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-15.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newbury Pharmaceuticals AB  (OSTO:NEWBRY) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Newbury Pharmaceuticals AB Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Newbury Pharmaceuticals AB's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Newbury Pharmaceuticals AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Newbury Pharmaceuticals AB (OSTO:NEWBRY) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XSAT:ACUC OSTO:KLAR XSAT:ODI XSAT:PMED OSTO:VIVE XSAT:DANCAN OSTO:TOL OSTO:GABA OSTO:ERMA OSTO:NANEXA ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS
Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Website
https://www.newburypharma.com
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.

Newbury Pharmaceuticals AB Headlines

No Headlines